FSSAI’s ‘Food’ Fortification Move Unscientific: NGOs

Kochi : Agriculture welfare organizations have asked Food Safety and Standards Authority of India (FSSAI) to reconsider the proposal to make mandatory fortification of edible oil with Vitamin A and Vitamin D and rice with Vitamin B12, iron and folic acid.

“While we agree with FSSAI’s diagnosis that India faces a huge nutritional challenge, we strongly disagree with its prescription. We strongly urge FSSAI not to pursue this route and at the same time promote and highlight alternatives as well,” said Usha Soolapani, director of Thanal and co-convenor, Alliance for Sustainable and Holistic Agriculture (ASHA).

ASHA, which is an informal alliance of more than 400 organizations from across India working among other themes on sustainable agriculture and safe, diverse, sufficient and nutritious food, has flagged the move as ‘scientifically unproven’. Industry groups like Global Alliance for Improved Nutrition (GAIN) with which FSSAI’s food fortification resource centre works should not be involved in such assessment at all. GAIN has companies like BASF, Royal DSM amongst others, which carry a serious conflict of interest, in that they benefit from the huge market to be gained from fortification and their involvement is highly objectionable.

There are concerns around overdose, which is a major issue with mandatory fortification in that it does not discriminate for dosage within a given  population.

A study last year by Anura Kurpad, head of physiology at St John’s Medical Institute, Bengaluru, had cautioned that food fortification and iron tablet supplementation may expose women to excess iron, ASHA said in a statement.

There’s a need to promote awareness, working with other bodies and non-government organizations who are working on low cost, sustainable solutions, such as kitchen gardens, bran in diet and nutrition-rich diverse varieties of crops, suggests ASHA.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states